Prestige Consumer Healthcare
PBH
#4654
Rank
S$2.92 B
Marketcap
S$61.75
Share price
0.75%
Change (1 day)
-21.92%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): S$4.62

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$4.60. In 2025 the company made an earnings per share (EPS) of S$4.88 a decrease over its 2024 EPS that were of S$5.51.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.62-5.27%
2025S$4.88-11.4%
2024S$5.51-367.08%
2023S-$2.06-138.33%
2022S$5.3811.7%
2021S$4.8113.6%
2020S$4.24-651.67%
2019S-$0.77-148.78%
2018S$1.57-83.29%
2017S$9.42437.23%
2016S$1.75-34.13%
2015S$2.6652.94%
2014S$1.74-8.11%
2013S$1.89
2011S$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.18 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.66 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.53 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.99-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$7.91 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$2.96-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.09-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.93-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.56-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel